Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN114195726B details a novel CuCl-catalyzed route for trifluoromethyl triazoles. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel chiral phosphoric acid catalysis enables high-yield indoline pyrrole synthesis. Cost-effective scalable production for pharmaceutical intermediates supply chain.
Patent CN113980028A details a mild, scalable method for chiral spiro indolones using cinchona alkaloid catalysts, offering high stereoselectivity for pharmaceutical intermediates.
Patent CN112239456B details a novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering high yields and simplified supply chains for API intermediates.
Novel Rh(III)-catalyzed C-H activation route for C2-sulfonamido indoles. Optimized process offers significant cost reduction in API manufacturing and simplified purification.
Patent CN115215810B reveals catalyst-free synthesis for high-purity triazoles. Enables cost reduction and scalable supply chain for pharmaceutical intermediate manufacturing globally.
Novel nitroxide catalyst enables high-yield azlactone ring opening. Reduces costs in pharmaceutical intermediate manufacturing with superior enantioselectivity.
Patent CN114163436A details a Pd-catalyzed route for indolizine-diarylmethanes. Delivers high-purity API intermediates with scalable cost reduction strategies.
Patent CN111196791B reveals a novel Rh-catalyzed route to chiral gamma-butyrolactones with high enantioselectivity, offering cost-effective API intermediate solutions.
Novel one-pot Rh(III) catalysis for nitrogen heterocycles. High yield, mild conditions, cost-effective supply chain solution.
Patent CN115215810B reveals catalyst-free synthesis for trifluoromethyl triazoles. Enables cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN118126005B reveals metal-free synthesis for high-purity pharmaceutical intermediates. Achieve cost reduction in fine chemical manufacturing with scalable air atmosphere reactions.
Patent CN113045503B reveals a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering high yields and scalable API intermediate manufacturing.
Novel nickel-catalyzed method for 2-pyrrolidone derivatives offers cost-effective scalable synthesis for pharmaceutical intermediates supply chain optimization and high purity standards.
Patent CN118164892A details a novel palladium-catalyzed route for 3-alkynyl indoles. This method offers significant supply chain reliability and cost reduction advantages for pharmaceutical manufacturing.
Novel organocatalytic synthesis of axially chiral 1-aryl indoles via spirophosphoric acid. Offers mild conditions and high enantioselectivity for glioma drug development.
Novel palladium-catalyzed carbonylation for indole-3-carboxamide. Efficient, scalable process for pharmaceutical intermediates. Cost-effective supply chain solution.
Patent CN117164506B reveals efficient palladium-catalyzed carbonylation. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112125856A details a Pd-catalyzed carbonylation route for 2-CF3 quinazolinones, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel transition-metal-free synthesis of benzothienopyridines via nitrile cyclization. High atom economy, scalable process for API intermediates.